01 / DESIGN
What was studied?
An open-label randomized trial compared a defined chemically synthesized formulation with a reference medicine in Chinese adults with obesity without diabetes.
02 / FINDINGS
What did the researchers report?
The between-group weight-change estimate fell inside the study's predefined equivalence margin. Reported adverse-event frequencies were similar for these two study products.
03 / LIMITS
How should it be interpreted?
Equivalence depends on the tested formulations, margin, population and follow-up. It cannot be extended to an unrelated supplier vial just because the ingredient name is the same.
Loti Labs Peptide editorial reading note. Based on the linked source record. Methods and corrections.